A Tale of Two Usanas

A new report by Fraud Discovery Institute contrasts the two Usanas that exist. There is one Usana story told to potential distributors (make lots of money!) and a different story told to Wall Street (only 12% actually want to make money!).

There’s one story about Research & Development given to the media (we are cutting edge – we spend lots!), and a different story told by the financial statements (Usana spends less than 1% of net sales on R&D).

There’s one truth about losing money with the Usana business opportunity (Dave Wentz says it only happens if you throw vitamins in the garbage), and a reality experienced by many failed distributors like Jane Bishop (she lost $5,000).

The media is told that Usana associates make lots of money, but Usana’s own documents show that:

• 72.2% of commission is paid to the top 2.6% of associates
• 67% of associates don’t even receive a dime in commissions
• 86% of associates don’t even make enough in commissions to pay for their vitamins

I wonder what the Usana executives have to say about this…

Related posts:

1. Questions raised about the figures reported in USANA’s SEC filings
2. Usana’s definition of “misinformation”
3. How Many “Active” Usana Associates?
4. Gil Fuller, CFO of Usana, says almost no one wants to make money in Usana anyway
5. A commentary on Usana Health Sciences